Concussive brain injury (CBI), the pathophysiological substrate underlying clinical concussion, is a frequent yet insufficiently understood condition with potential long-term neurological impairment in a subset of patients. Especially repetitive CBI, i.e., in contact sports, has been associated with lasting cognitive deficits and progressive neurodegeneration (e.g., chronic traumatic encephalopathy, CTE). To address this knowledge gap, a reproducible mouse model of closed-head rotational brain injury that recapitulates key biomechanical and pathological features of CBI was established. A stereotactically guided electromagnetic impactor was used to deliver a standardized strike to the intact skull. To reduce focal strain on the skull and adjacent brain tissue, the impactor tip was fitted with a custom-made silicone cap. This configuration reliably induced head rotation with low inter-animal variability while preventing skull fractures or microscopic tissue injury. To preserve physiological neuronal and vascular activity and to avoid potentially neuromodulatory effects of deep anesthesia, brain injury was induced in conscious mice under light sedation using the α2-agonist medetomidine. The induced impacts caused reproducible rotational head motion with only minor variability attributable to head positioning. Structural brain integrity was assessed using in vivo T2-weighted magnetic resonance imaging and confirmed by ex vivo histological analyses, which revealed no evidence of tissue disruption, contusion, or microbleeds but demonstrated a mild, widespread disruption of the microvascular interface. This novel model of rotational closed-head brain injury provides a robust experimental platform for longitudinal investigations of subtle neurovascular, inflammatory, and blood-brain barrier alterations that occur in the absence of overt structural pathology. Its application enables mechanistic insights into the pathophysiology of clinical concussion and potential neurodegenerative consequences of repetitive injury, thereby facilitating the development of urgently needed clinical biomarkers.